4.6 Review

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer

Related references

Note: Only part of the references are listed.
Article Microbiology

Chloroquine Inhibition of Autophagy Enhanced the Anticancer Effects of Listeria monocytogenes in Melanoma

Zuhua Yu et al.

Summary: This study demonstrated that Listeria monocytogenes (LM) exhibits antitumor effects by inducing autophagy, and the combination of LM and the autophagy inhibitor chloroquine (CQ) enhances the antitumor activity of LM both in vitro and in vivo.

MICROORGANISMS (2023)

Review Biochemistry & Molecular Biology

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

Li Yang et al.

Summary: Microorganisms, particularly the intratumoral microbiota, have significant impacts on human health, affecting cancer initiation, development, and therapy efficacy. While the intratumoral microbiota can promote cancer through various mechanisms, it also plays a dual role in antitumor immunity, both enhancing and suppressing immune responses. The composition of the microbiota, its interaction with cancer cells, and the cancer status all contribute to its effects on cancer physiology and the immune response, making it a potential diagnostic, prognostic, and therapeutic target in cancer.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Immunology

Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas

Yu Huang et al.

Summary: The composition and diversity of microbiota in human tumors are associated with the survival of pancreatic ductal adenocarcinoma (PDAC) patients. The microbiome in tumor samples from different survival time groups was significantly different, and the differential bacterial composition was associated with metabolic pathways in the tumor microenvironment. Additionally, administration of Megasphaera, a differential bacterium, combined with anti-PD-1 treatment showed better tumor growth inhibition effect in mice.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1

John A. McCulloch et al.

Summary: An integrated analysis of microbiome and host cell transcriptional data in patients with melanoma treated with anti-PD-1 therapy reveals new associations between streptococcus species and immune-related adverse effects. The study also identifies consistent microbiome associations with clinical outcomes. The results show that baseline microbiota composition is optimally associated with clinical outcome one year after treatment initiation. Meta-analysis and bioinformatic analyses reveal that bacteria associated with favorable response are within the Actinobacteria phylum and Lachnospiraceae/Ruminococcaceae families of Firmicutes. Gram-negative bacteria, on the other hand, are associated with an inflammatory host intestinal gene signature and unfavorable outcome. Two different microbial signatures, enriched for Lachnospiraceae spp. and Streptococcaceae spp., are associated with favorable and unfavorable clinical response, respectively, along with distinct immune-related adverse effects. Supervised learning algorithms consistently predict treatment outcomes in all cohorts, despite heterogeneity between cohorts. The study provides valuable insights into the complex interaction between gut microbiome and response to cancer immunotherapy, paving the way for future research.

NATURE MEDICINE (2022)

Review Oncology

Neutrophil Extracellular Traps and Pancreatic Cancer Development: A Vicious Cycle

Michail Mitsis et al.

Summary: This study summarizes the role of neutrophil extracellular traps (NETs) in the development of pancreatic adenocarcinoma (PDAC). The results suggest that NETs have a dual role in PDAC progression and metastasis, promoting cancer cell proliferation and invasion while also potentially leading to cancer-associated thrombosis. The interplay between inflammation and cancer progression may be involved in these mechanisms.

CANCERS (2022)

Review Oncology

BCG in Bladder Cancer Immunotherapy

Song Jiang et al.

Summary: Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis primarily used as a vaccine against tuberculosis. In the past four decades, it has also been utilized for the treatment of non-muscle invasive bladder cancer (NMIBC). In patients with NMIBC, BCG decreases the risk of tumor recurrence and progression to more invasive disease by activating both the innate and adaptive arms of the immune system. This article reviews the current data on the mechanism of BCG, as well as the clinical efficacy, recommended indications, and practice for BCG treatment of bladder cancer.

CANCERS (2022)

Review Cell Biology

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Tianyi Zhang et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a high deposition of extracellular matrix (ECM) and poor prognosis. ECM proteins derived from tumor cells reduce the effectiveness of conventional cancer treatment and contribute to tumor progression and metastasis. Cancer-associated fibroblasts (CAFs) in the ECM are promising targets for novel anti-tumor interventions.

CELL DEATH & DISEASE (2022)

Article Oncology

Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer

Ashley M. Mello et al.

Summary: Hypoxia plays a crucial role in promoting the inflammatory phenotype in cancer-associated fibroblasts (CAF) in pancreatic ductal adenocarcinoma (PDAC).

ONCOGENESIS (2022)

Article Immunology

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma

Xianlong Chen et al.

Summary: This study investigates the clinical significance of tumor-infiltrating neutrophils and macrophages, as well as the related extracellular traps (ETs), in pancreatic ductal adenocarcinoma (PDAC). The results show that neutrophil infiltration and ET formation are associated with patient prognosis and response to chemotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

The Role of the Microbiome in Pancreatic Cancer

Koji Miyabayashi et al.

Summary: Pancreatic cancer is influenced by the microbiome, which affects the tumor microenvironment and immune system, ultimately impacting the efficacy of chemotherapy. Understanding the role and mechanisms of the microbiome can lead to new therapeutic strategies and biomarkers.

CANCERS (2022)

Article Oncology

Downregulation of AKT/mTOR signaling pathway for Salmonella-mediated autophagy in human anaplastic thyroid cancer

Li-Hsien Wu et al.

Summary: Thyroid cancer is the most common endocrine malignancy, and Salmonella can inhibit the growth of anaplastic thyroid cancer by activating the autophagy signaling pathway.

JOURNAL OF CANCER (2022)

Review Oncology

Autophagy as a therapeutic target in pancreatic cancer

Max Piffoux et al.

Summary: PDAC is characterized by early metastasis and resistance to therapy, with mutations in KRAS and TP53 showing little clinical efficacy. Autophagy, upregulated in PDAC, plays a role in resistance to treatments, making it a potential therapeutic target. Combining inhibitors of the ERK/MAPK pathway with autophagy inhibitors has shown interesting results in PDAC models and other KRAS-driven cancers.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors

Filip Janku et al.

Summary: The first-in-human study on intratumoral injection of Clostridium novyi-NT demonstrated its feasibility with manageable toxicities. The treatment induced antitumor responses and host immune reactions in patients, with most experiencing reduction or stability in injected tumor size. Further studies are warranted to explore the potential of C. novyi-NT in human therapy.

CLINICAL CANCER RESEARCH (2021)

Review Cell Biology

Regulation and function of autophagy in pancreatic cancer

Jingbo Li et al.

Summary: Autophagy is a degradation system that can remove abnormal proteins and damaged organelles, with impaired autophagy being a pathological feature of diseases like pancreatic cancer. Dysfunctional autophagy plays a complex role in pancreatic tumor biology, with targeting selective autophagy potentially reducing side effects of drugs.

AUTOPHAGY (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch et al.

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

Review Biochemistry & Molecular Biology

Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients

Heidelinde Sammallahti et al.

Summary: Pancreatic cancer and the microbiota have complex interactions, with the microbiota playing a significant role in the development of pancreatic cancer, although the mechanisms are not completely clear. Dysbiosis may lead to the development of pancreatic cancer by altering host metabolism and immune responses. Additionally, the microbiota may also influence the efficacy of pancreatic cancer treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)

Xing Huang et al.

Summary: This review comprehensively summarizes the role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (PDAC) and the associated molecular mechanisms, aiming to provide a novel direction for improving treatment response and proposing potential directions for further research.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Microbiology

Avoiding the trap: Mechanisms developed by pathogens to escape neutrophil extracellular traps

A. L. Rios-Lopez et al.

Summary: This article discusses the resistance of neutrophil extracellular traps (NETs) against pathogens and summarizes the different mechanisms used by pathogens to evade the antimicrobial effect of NETs.

MICROBIOLOGICAL RESEARCH (2021)

Article Multidisciplinary Sciences

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer et al.

Summary: The study suggests that dietary fiber intake is associated with significantly improved progression-free survival in melanoma patients receiving ICB treatment, especially without the use of probiotics. Preclinical studies demonstrate that a low-fiber diet or probiotics can impair the treatment response to anti-PD-1 therapy, leading to a lower frequency of interferon-gamma-positive cytotoxic T cells in the tumor microenvironment.

SCIENCE (2021)

Review Chemistry, Multidisciplinary

Bacteria-Based Cancer Immunotherapy

Xuehui Huang et al.

Summary: Bacteria-based cancer immunotherapy has garnered significant attention in the past decade due to its unique mechanism and diverse applications. Bacteria are capable of targeting and colonizing tumor core areas, enhancing immune cell activation in the tumor microenvironment, and promoting specific immune recognition and elimination of tumor cells. The field also benefits from advancements in synthetic biology, allowing for creative immunotherapy paradigms using genetically modified bacteria and the combination of bacteria with nanomaterials for multifunctional cancer immunotherapy.

ADVANCED SCIENCE (2021)

Article Cell Biology

Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR/ERK pathway

Wei Jin et al.

Summary: NETs play important roles in the progression of pancreatic cancer, promoting migration, invasion, and epithelial-mesenchymal transition of cancer cells through the IL-1 beta/EGFR/ERK pathway. Targeting NETs may provide promising therapeutic strategies for pancreatic cancer.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Cell Biology

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth

Paul Manoukian et al.

Summary: Pancreatic tumors are characterized by abundant and highly desmoplastic stroma, with cancer-associated fibroblasts (CAFs) playing a crucial role in tumor development and architecture. However, the heterogeneity in CAF populations and the exact sources and functions of different CAF phenotypes remain to be fully understood. Understanding the roles of different subsets of CAFs within the stroma and the cellular dynamics that contribute to heterogeneity may be essential for developing novel therapies to improve clinical outcomes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Nanotechnology and pancreatic cancer management: State of the art and further perspectives

Damiano Caputo et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed too late for adequate treatment, and there is a lack of low-cost and non-invasive tools for early detection. Nanotechnology is becoming increasingly important in both early detection and treatment of PDAC, with nanoparticles showing high sensitivity and specificity in blood tests. Nanoparticles can also be used as nanocarriers for targeted drug delivery in cancer therapy.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Review Oncology

Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis

Urszula Demkow

Summary: This review focuses on the pro-tumorigenic action of neutrophil extracellular traps (NETs), which are found in various human and animal tumors. NETs play a crucial role in tumor development by awakening dormant cancer cells, regulating the tumor microenvironment, and enhancing tumor aggressiveness. Understanding the crosstalk between cancer and NETs can lead to novel therapeutic interventions to block cancer evasion mechanisms and prevent metastatic spread.

CANCERS (2021)

Article Medicine, Research & Experimental

DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

Jenying Deng et al.

Summary: The study reveals that DDR1 activation in cancer cells induced by collagen is a major stimulus for the production of CXCL5, leading to the recruitment of TANs and formation of NETs, promoting cancer cell invasion and metastasis in PDAC. Furthermore, the collagen-induced CXCL5 production is mediated by a DDR1/PKC theta/SYK/NF-kappa B signaling cascade.

JCI INSIGHT (2021)

Review Biochemistry & Molecular Biology

Mucin in cancer: a stealth cloak for cancer cells

Dong-Han Wi et al.

Summary: Mucins are high molecular-weight epithelial glycoproteins that play a role in creating a tumor-friendly environment and enabling tumor cells to evade immune surveillance, thereby contributing to increased cancer malignancy.

BMB REPORTS (2021)

Review Oncology

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Brendan Fu-Long Sieow et al.

Summary: Recent advances in cancer biology, microbiology, and bioengineering have led to the development of engineered live biotherapeutics for targeted cancer therapy. Engineered bacteria, including tumor-targeting and probiotics, can deliver anticancer agents to the tumor microenvironment. Combination therapies involving engineered bacteria and traditional anticancer treatments show promise in addressing intratumor heterogeneity. Exciting prospects lie ahead for the clinical translation of engineered bacteria in cancer prevention and treatment.

TRENDS IN CANCER (2021)

Review Immunology

The cGAS-STING pathway as a therapeutic target in inflammatory diseases

Alexiane Decout et al.

Summary: The cGAS-STING signaling pathway plays a crucial role in inflammation in infection, cellular stress, and tissue damage settings. It has the ability to sense and regulate cellular responses to DNA and has the potential to be targeted in the treatment of various inflammatory diseases.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma

Jia-qiao Fan et al.

MOLECULAR CANCER (2020)

Review Oncology

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

Panagiotis Sarantis et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma

Christopher Montemagno et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity

Rodolfo Chavez-Dominguez et al.

FRONTIERS IN ONCOLOGY (2020)

Editorial Material Oncology

Challenges and Opportunities for Effective Cancer Immunotherapies

Clare Y. Slaney et al.

CANCERS (2020)

Article Biochemistry & Molecular Biology

Cytokines in the Treatment of Cancer

Kevin C. Conlon et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)

Article Multidisciplinary Sciences

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

V. Gopalakrishnan et al.

SCIENCE (2018)

Article Biochemistry & Molecular Biology

Surface-exposed loops and an acidic patch in the Scl1 protein of group A Streptococcus enable Scl1 binding to wound-associated fibronectin

Dudley H. McNitt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Chemistry, Multidisciplinary

Potentiating bacterial cancer therapy using hydroxychloroquine liposomes

Ying Wang et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Article Multidisciplinary Sciences

Fibronectin-guided migration of carcinoma collectives

Sandeep Gopal et al.

NATURE COMMUNICATIONS (2017)

Review Oncology

nab-Paclitaxel for the treatment of pancreatic cancer

George Kim

CANCER MANAGEMENT AND RESEARCH (2017)

Review Nutrition & Dietetics

Surfacing role of probiotics in cancer prophylaxis and therapy: A systematic review

Subramanyam Dasari et al.

CLINICAL NUTRITION (2017)

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

Evasion of Neutrophil Extracellular Traps by Respiratory Pathogens

Daniel M. L. Storisteanu et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Structural characterization of the virulence factor Sda1 nuclease from Streptococcus pyogenes

Andrea F. Moon et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Oncology

Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation

Shenghong Yang et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Review Biochemistry & Molecular Biology

Clostridium novyi-NT in cancer therapy

Verena Staedtke et al.

GENES & DISEASES (2016)

Review Biotechnology & Applied Microbiology

Targeted radionuclide therapies for pancreatic cancer

M. Shah et al.

CANCER GENE THERAPY (2015)

Article Medicine, Research & Experimental

Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1 beta

Jung-Eun Kim et al.

THERANOSTICS (2015)

Review Urology & Nephrology

Immunotherapy for bladder cancer

Oliver Fuge et al.

RESEARCH AND REPORTS IN UROLOGY (2015)

Article Oncology

Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation

Wen-Wei Chang et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Article Multidisciplinary Sciences

Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer

Wilber Quispe-Tintaya et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Biochemical Research Methods

Killed but metabolically active vaccines

Thomas W. Dubensky et al.

CURRENT OPINION IN BIOTECHNOLOGY (2012)

Article Gastroenterology & Hepatology

Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

Mitsuro Kanda et al.

GASTROENTEROLOGY (2012)

Article Microbiology

Effect of Salmonella Treatment on an Implanted Tumor (CT26) in a Mouse Model

Misun Yun et al.

JOURNAL OF MICROBIOLOGY (2012)

Review Immunology

Potential targets for pancreatic cancer immunotherapeutics

Lindzy F. Dodson et al.

IMMUNOTHERAPY (2011)

Review Oncology

Harnessing Listeria monocytogenes to target tumors

Claudia Gravekamp et al.

CANCER BIOLOGY & THERAPY (2010)

Review Cell Biology

Genetics and biology of pancreatic ductal adenocarcinoma

Aram F. Hezel et al.

GENES & DEVELOPMENT (2006)

Article Oncology

Differences in survival by histologic type of pancreatic cancer

MD Fesinmeyer et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)

Review Oncology

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

RFM Bevers et al.

BRITISH JOURNAL OF CANCER (2004)

Review Biochemistry & Molecular Biology

Molecular regulation of pancreatic stellate cell function

Robert Jaster

MOLECULAR CANCER (2004)

Article Biochemistry & Molecular Biology

Streptococcal Scl1 and Scl2 proteins form collagen-like triple helices

Y Xu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)